Skip to contentI
INSMED Inc
I
INSMINSMED Inc Q4 2018 · 10-K
Revenue$9.84M$9.84M— vs Q4 2017 Net Income-$91.57M-$91.57MN/M vs Q4 2017 EPS Diluted-$1.19-$1.19N/M vs Q4 2017 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
INSMED Inc · CIK 1104506 · Engraved from SEC EDGAR
Operating Cash Flowderived-$70,164,000N/M Free Cash Flowderived-$73,191,000N/M Margins · derivedGross margin75.4%
Operating margin-891.9%
Net margin-931.1%
ended Dec 31, 2018 · filed Feb 22, 2019 · 53 d after period end